pentetic acid has been researched along with Hyaline Membrane Disease in 3 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jefferies, AL | 1 |
| Coates, G | 3 |
| O'Brodovich, H | 3 |
1 review available for pentetic acid and Hyaline Membrane Disease
| Article | Year |
|---|---|
Measurement of pulmonary epithelial permeability with 99mTc-DTPA aerosol.
Topics: Aerosols; Alveolitis, Extrinsic Allergic; Half-Life; Humans; Hyaline Membrane Disease; Infant, Newbo | 1986 |
2 other studies available for pentetic acid and Hyaline Membrane Disease
| Article | Year |
|---|---|
Pulmonary epithelial permeability in hyaline-membrane disease.
Topics: Aerosols; Animals; Capillary Permeability; Epithelium; Female; Half-Life; Humans; Hyaline Membrane D | 1984 |
Pulmonary clearance of 99mTc-DTPA in infants who subsequently develop bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Half-Life; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Meta | 1988 |